Holen Sie sich die Stockscreener-App
1.04
9.57%
-0.11
Handel nachbörslich:
1.05
0.01
+0.96%
Schlusskurs vom Vortag:
$1.15
Offen:
$1.15
24-Stunden-Volumen:
1.68M
Relative Volume:
0.36
Marktkapitalisierung:
$149.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-119.76M
KGV:
-0.7704
EPS:
-1.35
Netto-Cashflow:
$-55.17M
1W Leistung:
-20.61%
1M Leistung:
+4.00%
6M Leistung:
+125.89%
1J Leistung:
-88.56%
1-Tages-Spanne:
$1.03
$1.15
1-Wochen-Bereich:
$1.03
$1.31
52-Wochen-Spanne:
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Firmenname
Applied Therapeutics Inc
Sektor
Branche
Telefon
212-220-9226
Adresse
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Vergleichen Sie APLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
1.04 | 165.61M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-23 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Eingeleitet | William Blair | Outperform |
| 2024-03-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-22 | Eingeleitet | Leerink Partners | Outperform |
| 2022-01-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Herabstufung | Goldman | Neutral → Sell |
| 2021-06-25 | Fortgesetzt | Goldman | Neutral |
| 2020-10-08 | Eingeleitet | Truist | Buy |
| 2020-04-22 | Eingeleitet | Goldman | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-06-10 | Eingeleitet | Citigroup | Buy |
| 2019-06-10 | Eingeleitet | Cowen | Outperform |
| 2019-06-10 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Applied Therapeutics Inc Aktie (APLT) Neueste Nachrichten
News impact scoring models applied to Applied Therapeutics Inc.2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Real time alert setup for Applied Therapeutics Inc. performanceChart Signals & Daily Entry Point Alerts - newser.com
What makes Applied Therapeutics Inc. stock attractive to growth funds2025 Top Decliners & Technical Confirmation Trade Alerts - newser.com
Applied Therapeutics Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Custom watchlist performance reports with Applied Therapeutics Inc.July 2025 WrapUp & Daily Profit Focused Stock Screening - newser.com
Can Applied Therapeutics Inc. (2UV) stock double in coming yearsDividend Hike & Expert-Curated Trade Recommendations - newser.com
Can Applied Therapeutics Inc. (2UV) stock surprise markets with earnings2025 Institutional Moves & Growth Focused Investment Plans - newser.com
Can a trend reversal in Applied Therapeutics Inc. lead to recoveryJuly 2025 Breakouts & Consistent Profit Focused Trading Strategies - newser.com
Will Applied Therapeutics Inc. stock recover faster than peersQuarterly Investment Review & Free Reliable Trade Execution Plans - newser.com
Statistical indicators supporting Applied Therapeutics Inc.’s strengthWall Street Watch & Expert Curated Trade Setups - newser.com
How geopolitical tensions affect Applied Therapeutics Inc. stockTrade Risk Report & Weekly Sector Rotation Insights - newser.com
Does Applied Therapeutics Inc. show high probability of reboundWeekly Investment Recap & AI Optimized Trading Strategy Guides - newser.com
Can Applied Therapeutics Inc. (2UV) stock ride next bull market cycleQuarterly Risk Review & Free Weekly Watchlist of Top Performers - newser.com
Is Applied Therapeutics Inc. (2UV) stock among top earnings playsEarnings Growth Summary & Long-Term Safe Investment Plans - newser.com
Applying big data sentiment scoring on Applied Therapeutics Inc.Rate Cut & High Return Trade Opportunity Guides - newser.com
Is Applied Therapeutics Inc. stock a good choice for value investorsMarket Performance Recap & Weekly Return Optimization Alerts - newser.com
Are Analysts Too Optimistic About Bajaj Consumer Care Limiteds Revenue GrowthMarket Breadth Indicators & Low Cost Trading Plans - earlytimes.in
What data driven models say about Applied Therapeutics Inc.’s futureMarket Growth Summary & Real-Time Volume Analysis - newser.com
Why Applied Therapeutics Inc. (2UV) stock is a must watch tickerPortfolio Value Summary & Long-Term Growth Plans - newser.com
Analyzing Applied Therapeutics Inc. with multi timeframe chartsWeekly Investment Report & Verified Short-Term Trading Plans - newser.com
What does recent volatility data suggest for Applied Therapeutics Inc.Entry Point & Short-Term Trading Opportunity Alerts - newser.com
Applied Therapeutics (APLT) Projected to Post Earnings on Thursday - MarketBeat
Volume spikes in Applied Therapeutics Inc. stock – what they meanJuly 2025 Rallies & Verified Entry Point Detection - newser.com
What makes IVCAW stock price move sharply - newser.com
Developing predictive dashboards with Applied Therapeutics Inc. dataTrade Exit Summary & Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-30 23:56:28 - newser.com
Finanzdaten der Applied Therapeutics Inc-Aktie (APLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):